JFG
ATYR

Jefferies Financial Group’s aTyr Pharma ATYR Stock Holding History

Jefferies Financial Group’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55,600
Closed -$168K – 1899
2025
Q1 		$168K Hold
55,600
– – ﹤0.01% 1419
2024
Q4 		$201K Hold
55,600
– – ﹤0.01% 1382
2024
Q3 		$97.9K Buy
+55,600
New +$101K ﹤0.01% 1304

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jefferies Financial Group's ATYR Position: Q2 2025 in Review

Jefferies Financial Group sold out of aTyr Pharma (ATYR) in Q2 2025, closing a stake of 55,600 shares — an estimated $168K sold.

Jefferies Financial Group first reported a position in ATYR in Q3 2024 and held it in 3 quarters. The position peaked at $201K in Q4 2024. 110 funds tracked by Wall St. Rank hold ATYR as of Q2 2025.

  • Jefferies Financial Group reported no remaining aTyr Pharma position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 55,600 aTyr Pharma shares in Q2 2025, an estimated $168K.
  • Jefferies Financial Group first reported a position in aTyr Pharma in Q3 2024 and held it in 3 quarters.
  • Jefferies Financial Group's aTyr Pharma position peaked at $201K in Q4 2024.
  • 110 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.